| Prev Close | 152.53 |
| Open | 154.76 |
| Day Low/High | 150.74 / 155.60 |
| 52 Wk Low/High | 95.65 / 164.76 |
| Volume | 296.18K |
| Avg Volume | 394.90K |
| Exchange | NASDAQ |
| Shares Outstanding | 25.30M |
| Market Cap | 3.77B |
| EPS | -6.60 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
While cannabis remains illegal on a federal level, these seven names are making early inroads into the growing industry.
It's important to know the difference between broken stocks and broken companies.
Jim Cramer shines a spotlight on Snap, Costco, Seagate Technology, GW Pharmaceuticals, Danaher, General Mills and more.
We have a wall of worry to overcome, but it's important to hear the other side of the trade, says Jim Cramer. Take Apple and Facebook, for example.
A string of good news for the cannabis sector may prompt institutional investors to get into the game, but watch valuations increase.
Jim Cramer says analysts and trade woes put a damper on buying ahead of the weekend. So let's get the game plan for next week.
The game plan is to spot the charts that have more room to run.
Jim Cramer takes a closer look at American Electric Power, Fifth Third Bancorp, Applied Materials, EPR Properties, GW Pharmaceuticals and Longfin.
Jim Cramer calls it a tsunami of selling. Not one sector of the stock market got a break in Thursday's tariff-inspired decline.
MAA seeking regulatory approval of Epidiolex for seizures associated with Lennox-Gastaut syndrome and Dravet syndrome
Here's a look at biotech stock trades, takeout targets and pot sellers that will dominate 2018.
Look for this name to jump quickly in popularity in 2018 as investors players search for a convenient way to play the marijuana niche.
Consumers in California eagerly await the end to it prohibition on the recreational use of cannabis.
- Previous License Agreement with Otsuka Terminated -
